Lactiga named a Semi-Finalist in the XPRIZE Rapid Covid Testing Competition

Sep 12, 2020 | Announcements

Lactiga has been advanced to the Semi-Final stage of the XPRIZE Rapid Covid Testing Competition, a $5 million dollar, 6-month competition to develop faster, cheaper, and easier to use COVID-19 testing methods at scale.

Lactiga featured in the Globe and Mail

Lactiga was featured in The Globe and Mail for its COVID-19 therapeutics program: https://www.theglobeandmail.com/canada/article-can-antibodies-from-human-breast-milk-help-in-the-covid-19-fight/

Lactiga featured in the Toronto Star

Lactiga’s R&D on milk antibodies against COVID-19 was featured in the Toronto Star, one of Canada’s largest newspapers: https://www.thestar.com/business/mars/2021/06/09/got-milk-covid-19-antibodies.html